Reproducibility, Statistical Rigor, and Methodological Transparency in Multi-Omics Analysis

1.1 The reproducibility crisis in computational biology

High-throughput omics technologies: lipidomics, metabolomics, transcriptomics, proteomics, metagenomics, and single-cell transcriptomics: have transformed biomedical research by enabling the simultaneous measurement of thousands of molecular features. Yet the analytical flexibility that makes these technologies powerful also makes them vulnerable to a reproducibility crisis documented across the life sciences. Surveys of published microarray, proteomics, and metagenomics analyses have found that a substantial fraction of results cannot be reproduced when independent groups re-analyze the same raw data, often because the original pipeline involved undocumented parameter choices, ad hoc filtering, or statistical tests inappropriate for the data structure.

The root causes are well understood: high-dimensional data invite researcher degrees of freedom (the many small decisions an analyst makes between raw data and a reported p-value), multiple testing inflates false-positive rates when uncorrected, and compositional data structures generate spurious correlations when treated with standard multivariate methods. These problems are compounded by the rapid proliferation of analysis tools whose internal implementations are opaque, making it impossible for reviewers or readers to verify exactly what computation produced a given figure.

This white paper addresses these concerns directly. It documents the statistical and computational foundations of the Om™ platform, a browser-native multi-omics analysis environment that performs all statistical computations in the client and persists analysis state locally. Om™ is the first product of OmVitalis Systems, a company dedicated to building privacy-first computational systems for every omics frontier. Users subscribe to the platform through OmVitalis Systems, and this paper serves as the methodological reference for all analyses performed on it. The paper is organized in two parts: Part I argues the principles of reproducibility, statistical rigor, and publication-readiness that the platform enforces by design; Part II provides a citable atlas of every statistical method implemented, with assumptions, limitations, and primary references. Together they provide the methodological transparency required for peer review and for users to cite the platform's analytical foundations in their own publications.

1.2 Scope and intended audience

This document is intended for biomedical researchers, bioinformaticians, peer reviewers, and journal editors who need to evaluate or cite the statistical methods used in analyses performed on the Om™ platform. It is not a user manual; it is a methodological reference. Every statistical engine described in Part II is implemented exactly as specified and is available for inspection through the platform's in-app Methods documentation. Where a method rests on a published algorithm, the original publication is cited; where the platform adds an implementation choice (e.g., default multiple-testing correction, default transformation), that choice is stated explicitly so it can be reported in a manuscript's Methods section.

The platform supports six omics workflows: lipidomics, metabolomics, transcriptomics, proteomics, metagenomics, and single-cell transcriptomics: plus cross-omics integration and causal inference modules. This paper covers the statistical methods common to all workflows and the methods specific to each. It does not cover data acquisition, instrument calibration, or laboratory protocols, which remain the responsibility of the data generator and are governed by community reporting guidelines cited where relevant.

2.1 Computational reproducibility versus replicability

A distinction is essential. Computational reproducibility: the ability to re-run the same analysis on the same data and obtain the identical result: is a necessary precondition for trustworthy science. Replicability: obtaining consistent results on new data: is a scientific goal that depends on biological and experimental factors beyond the analysis pipeline. This paper is concerned primarily with computational reproducibility: ensuring that any analysis performed on the platform can be exactly reconstructed and that the reconstruction yields byte-identical outputs.

The platform achieves computational reproducibility through three mechanisms. First, all statistical computations are deterministic: given the same input matrix and the same parameter settings, the engines produce identical results with no hidden randomness (bootstrap and permutation procedures use fixed seeds where applicable). Second, the complete analysis state: data, preprocessing parameters, group assignments, and every result: is serialized into a single project manifest that can be saved, shared, and reloaded. Third, reproducibility metadata (platform version, workflow identifier, parameter set, color palette, axis-link configuration) is embedded into every exported figure file, so a published figure carries a cryptographic-style fingerprint of the analysis that produced it.

2.2 Local-first architecture and data provenance

The platform's local-first architecture is a reproducibility feature, not merely a privacy feature. Raw data matrices are held in the browser's storage, and the platform's statistical computation runs in the browser, so the exact data analyzed is the exact data the user uploaded: there is no server-side normalization, no silent reformatting, no version drift between a data file and a remote pipeline. A small, named set of server-side paths exists for work a browser cannot do at scale: single-cell archive parsing, Olink export parsing, proteomics fitting methods, transcriptomics permutation and lncRNA assembly, and the metagenomics pipelines: and each is named in the platform's published data-egress table. The analysis state persisted to the cloud is a lightweight manifest containing parameters and results, not the raw data, so reloading a project on the same device restores the full computational context without re-upload.

Provenance: the record of what was done to the data: is maintained automatically. Each analysis step records its inputs, parameters, and outputs in a reproducibility log that travels with the project. When a user exports a figure or a report, this log is embedded as structured metadata, allowing a reviewer to trace a published result back to the specific preprocessing and statistical choices that produced it. This addresses a core requirement of the FAIR data principles: analyses must be not only reproducible but traceable.

2.3 Versioning and methodological stability

Statistical methods evolve. A correction introduced in a new version of a differential abundance engine may change which features are called significant, and a published result must remain interpretable long after the platform is updated. The platform addresses this by embedding the platform version into every exported artifact and by maintaining this white paper under semantic versioning. When a statistical method's implementation changes in a way that could alter results, the version is incremented and the change is recorded in the changelog (Section 20). Users who cite a specific version of this white paper cite a fixed, stable methodological description, even as the platform improves.

This versioning discipline mirrors the practice recommended for bioinformatics software by the journal Nucleic Acids Research: software should be cited by version, and methods should be documented at the level of detail that allows an independent analyst to reproduce the computation. The structured content of this paper is designed to be machine-readable as well as human-readable, so that the methodological description can be programmatically extracted and included in a manuscript's Methods section.

3.1 The multiple testing problem in high-dimensional data

Omics datasets routinely test thousands of features simultaneously. When each test is performed at a nominal significance level of α = 0.05, the expected number of false positives scales linearly with the number of tests: testing 10,000 features at α = 0.05 yields 500 expected false positives even under the complete null hypothesis. Failing to correct for multiplicity is the single most common statistical error in published omics analyses and is a primary driver of irreproducible biomarker lists.

The platform applies multiple testing correction by default in every differential analysis engine. The Benjamini-Hochberg (BH) procedure, which controls the false discovery rate (FDR): the expected proportion of false positives among all called significant features: is the default and the recommended standard for omics. The Bonferroni correction, which controls the family-wise error rate (the probability of any false positive), is available as a more conservative alternative. Holm-Bonferroni, a step-down procedure that is uniformly more powerful than Bonferroni while maintaining the same FWER control, is offered as an intermediate option. Users may disable correction for exploratory, hypothesis-generating analyses, but the platform flags this choice in the reproducibility log so it is visible to reviewers.

3.2 Effect sizes and statistical significance

A p-value alone is insufficient to characterize a finding. In large cohorts, trivially small differences can reach statistical significance, while in small cohorts, biologically meaningful effects may fail to reach significance. The platform therefore reports and visualizes effect sizes alongside p-values in every differential analysis: log₂ fold change for abundance differences, Cohen's d for standardized mean differences, and the LDA score for LEfSe. Volcano plots display both dimensions simultaneously, allowing the user to apply combined thresholds (e.g., |log₂FC| ≥ 1 AND adjusted p < 0.05) that filter for features that are both statistically supported and biologically meaningful.

This dual reporting aligns with the American Statistical Association's statement on p-values, which emphasizes that statistical significance is not a measure of effect size or practical importance, and that scientific conclusions should be based on the totality of evidence including effect size, confidence intervals, and study design, not solely on a p-value threshold. The platform's default reporting enforces this by surfacing effect sizes as first-class outputs, not afterthoughts.

3.3 Test selection and assumption verification

No statistical test is universally optimal, and applying a test whose assumptions are violated is worse than applying no test at all. The platform's differential abundance engines are selected based on the data structure: DESeq2's negative binomial model for RNA-seq count data, Limma's empirical Bayes moderated t-test for continuous intensity data, and non-parametric alternatives (Wilcoxon, Kruskal-Wallis) for small samples or heavily skewed distributions. The platform provides a data-driven test recommendation panel that inspects distributional properties (normality after transformation, sample size per group, presence of pairing) and recommends the appropriate test, rather than leaving the choice to the user's intuition.

Assumption verification is built into the workflow. Distribution QC plots (sample medians, density histograms, missing-value heatmaps, CV distributions) are displayed before any test is run, allowing the user to confirm that preprocessing has stabilized variance and removed systematic bias. PERMDISP is reported alongside PERMANOVA so that a significant multivariate result can be correctly attributed to a centroid shift rather than a dispersion difference. These diagnostics are not optional add-ons; they are integrated into the analysis flow because a test applied without verifying its assumptions is a test whose result cannot be trusted.

4.1 The compositional nature of omics data

Many omics data types: microbiome relative abundances, single-cell expression proportions, and any data normalized to a constant sum: are compositional: each sample's values sum to a constant (often 1 or 100%), so an increase in one feature's measured value necessarily decreases the measured values of all other features, regardless of any biological change. This constraint generates spurious negative correlations when standard correlation coefficients are applied directly to relative-abundance data, and it distorts distance-based analyses (PCA, hierarchical clustering) that assume the data occupy unconstrained Euclidean space.

The compositional data analysis framework, established by Aitchison, resolves these problems by working in log-ratio space, where ratios between features are invariant to the compositional constraint. The centered log-ratio (CLR) transform maps compositions to real-valued vectors whose Euclidean distance (the Aitchison distance) is subcompositionally coherent: meaning the result does not depend on which features are included in the analysis. The platform implements CLR transformation, Aitchison distance computation, and robust PCA on CLR-transformed matrices for compositional ordination, and uses compositional-aware differential abundance methods (ANCOM-BC2, ALDEx2) that do not test relative abundances directly.

4.2 Practical implications for analysis and interpretation

The practical consequence is that analyses must be matched to the data's structure. Applying a standard t-test to relative abundance data tests a quantity that is mathematically constrained and biologically uninterpretable; applying ANCOM-BC2, which models absolute abundance via a sampling-fraction correction, tests a quantity that can be interpreted as a true change in the feature's abundance. Similarly, Bray-Curtis dissimilarity, though widely used, is not subcompositionally coherent and can produce misleading ordinations on relative data; the Aitchison distance is the principled alternative and is provided.

The platform surfaces these distinctions in its method selection interfaces. When a user uploads compositional data, the recommended ordination and differential abundance methods default to compositional-aware options. When a user selects a non-compositional method on compositional data, the platform warns of the limitation. This is not paternalism; it is the recognition that compositional effects are subtle, easy to overlook, and a well-documented source of irreproducible microbiome and single-cell results. The methodological transparency provided here allows a reviewer to confirm that the appropriate framework was used.

5.1 From association to causation

Omics analyses typically identify associations: features that differ between groups or correlate with phenotypes. Association is necessary but not sufficient for causation, and the leap from 'X is associated with Y' to 'X causes Y' requires assumptions that cannot be verified from observational data alone. The platform's causal inference modules: counterfactual mediation analysis, Mendelian randomization, directed acyclic graph (DAG) construction, and multi-layer sequential mediation: make these assumptions explicit and provide sensitivity analyses that quantify how robust a causal estimate is to their violation.

The identifying assumptions are stated in the method documentation (Part II, Section 13) and are not hidden behind a button. Sequential ignorability for mediation, the instrumental variable assumptions for Mendelian randomization, and the back-door criterion for DAG-based covariate selection are each documented with their implications, their testable consequences, and their sensitivity parameters. A user who runs a mediation analysis sees not only the average causal mediation effect but also the ρ sensitivity parameter that quantifies how much residual confounding would be required to nullify the finding. This is the standard of transparency that causal inference demands and that observational omics analyses have historically lacked.

5.2 DAG-guided covariate selection

A core source of bias in observational analyses is incorrect covariate adjustment: adjusting for a collider opens a back-door path and induces spurious associations, while failing to adjust for a confounder leaves a back-door path open. The platform's DAG builder allows a researcher to encode prior causal knowledge as a directed graph and applies the back-door criterion to identify the minimal adjustment set that yields an unbiased causal effect estimate. This replaces the common practice of adjusting for 'all available covariates,' which can introduce bias rather than remove it.

The identified adjustment set can be fed directly into the mediation analysis or regression modules, closing the loop between causal theory and statistical estimation. This integration is important: a causal estimate is only as valid as the adjustment set that produced it, and an adjustment set is only valid if it is derived from a correct causal graph. The platform makes the graph inspectable and the adjustment set auditable, so a reviewer can verify that the covariates were chosen by principled criteria rather than convenience.

6.1 Community reporting guidelines

Biomedical journals require omics studies to adhere to community reporting standards that specify the minimum information needed for a study to be interpretable and reproducible. The platform's output formats are designed to facilitate compliance with these standards. Metabolomics analyses support the reporting of MIAMet (Minimum Information About a Metabolomics Experiment) and the metabolomics reporting guidelines of Broadhurst et al. Transcriptomics analyses support MIAME (Minimum Information About a Microarray Experiment) and the sequencing-specific MINSEQE. Proteomics analyses support the MIAPE (Minimum Information About a Proteomics Experiment) guidelines. Metagenomics analyses support the STORMS checklist for microbiome studies.

Compliance is facilitated by the platform's structured output: every differential analysis produces a results table with feature identifiers, log fold change, p-value, adjusted p-value, and effect size, which maps directly to the reporting fields these guidelines require. Enrichment analyses produce pathway-level statistics (enrichment ratio, p-value, adjusted p-value, gene set size) that satisfy the reporting requirements for pathway analysis. The reproducibility log embedded in exports provides the parameter documentation that guidelines require and that is frequently omitted from supplementary materials.

6.2 Figure quality and publication readiness

Publication-ready figures are not merely aesthetic; they are a reproducibility instrument. A figure that does not specify its axis scales, color encoding, statistical test, and sample sizes is a figure whose results cannot be verified. The platform's Figure Builder produces figures that embed reproducibility metadata: platform version, workflow, color palette, axis-link configuration: directly into the exported file (SVG, PNG, PDF, TIFF), so a published figure is self-documenting. Journal-specific sizing presets (Nature, Cell, etc.) ensure that figures meet submission requirements without manual resizing, which can introduce interpolation artifacts.

The export pipeline supports vector (SVG, PDF) and raster (PNG, TIFF) formats at publication resolutions (300, 600, 1200 DPI). Vector formats preserve scalability and are preferred for line plots and schematics; raster formats are required by some journals and are produced via canvas-based compositing that avoids the rendering failures associated with large nested SVGs. The choice of format is documented in the reproducibility metadata so a reviewer can confirm that the published figure is a faithful representation of the analysis output.

7.1 Hydration and verification

Data integrity: the assurance that the data being analyzed has not been corrupted, truncated, or silently modified: is a prerequisite for any trustworthy analysis. The platform implements a hydration-and-verification pattern: when a project is loaded, the saved state is verified against stored timestamps and checksums, and the user is alerted if the raw data matrix on the current device does not match the matrix that was originally analyzed. This catches the common failure mode in which a user re-uploads a file that has been re-exported or re-processed, introducing subtle differences that propagate through the entire analysis.

Large data matrices are stored in IndexedDB rather than in the cloud manifest: the raw data is not copied into the cloud record at all, so the saved state carries no measurement rows. This is both a privacy measure and an integrity measure: there is no server-side copy that could diverge from the user's local copy. When a project is loaded on a different device, the platform restores all parameters and results but flags that the raw data is unavailable, requiring re-upload: a transparent failure that prevents silent analysis of a substituted dataset.

7.2 Reproducibility metadata in exports

Every exported artifact: figure, report, results table: carries embedded metadata that records the platform version, the workflow, the specific analysis parameters, the color palette, and the axis-link configuration. This metadata is structured (JSON-serializable) and can be extracted by a reviewer or by an automated pipeline. It serves the same function as a version-control commit hash in software engineering: it provides a unique, verifiable identifier for the exact computational state that produced the artifact.

This practice directly addresses the concern, raised by the FAIR principles and by journal data-sharing policies, that published results must be traceable to a specific analysis. A reader who encounters a figure in a published manuscript can, in principle, extract the embedded metadata and confirm the platform version and parameter set, then re-run the analysis on the deposited data to verify the result. The platform does not require this level of scrutiny but makes it possible, which is the definition of computational reproducibility.

8.1 Distribution QC

Quality control plots assess the distributional properties of raw and processed omics data to detect systematic biases, outlier samples, and batch effects before downstream analysis. The platform computes four QC diagnostics: the sample median plot (per-sample median intensity, detecting pipetting or extraction errors), the value distribution histogram with kernel density overlay (detecting bimodality or failed normalization), the missing-value heatmap (per-feature and per-sample missingness, with features exceeding 20-50% missingness flagged for exclusion), and the coefficient of variation distribution (CV = σ/μ × 100%, with QC samples expected below 30% for untargeted and 15% for targeted assays).

QC checks must precede differential analysis, PCA, or any downstream modeling. Uncorrected technical variation inflates both false-positive and false-negative rates, and no multiple-testing correction can rescue an analysis performed on biased data. The platform integrates QC into the analysis flow as a mandatory first step, not an optional diagnostic.

9.1 Principal Component Analysis (PCA)

PCA is an unsupervised linear dimensionality-reduction technique that projects high-dimensional data onto orthogonal axes (principal components) explaining maximal variance. The data matrix is mean-centered (and optionally scaled to unit variance); eigendecomposition of the covariance matrix yields eigenvectors (loadings) and eigenvalues. Scores are computed by projecting samples onto the top principal components, with the percentage of total variance captured by PC1 and PC2 displayed on each axis. PERMANOVA (Anderson 2001) tests whether group centroids differ significantly in multivariate space, with R² quantifying the proportion of total variance explained by group membership and p-values derived by permuting group labels.

PCA captures linear structure only; non-linear patterns require UMAP or t-SNE. It is sensitive to extreme outliers and to the scaling choice (unit-variance scaling gives equal weight to all features; no scaling gives weight proportional to magnitude). The platform recommends PCA as a first-pass exploratory tool, followed by supervised methods (PLS-DA, differential abundance) to confirm group differences.

9.2 PLS-DA and OPLS-DA

Partial Least Squares Discriminant Analysis (PLS-DA) and its orthogonal extension (OPLS-DA) are supervised dimensionality-reduction methods that maximize the covariance between the feature matrix X and the class response Y. The NIPALS algorithm iteratively extracts latent variables maximally correlated with the response, each orthogonal to the previous in X-space. OPLS-DA separates the predictive component from structured orthogonal variation, and the S-plot visualizes the covariance (p[1]) and correlation (p(corr)[1]) of each feature with the predictive component: features in the extreme quadrants are ideal biomarker candidates.

Model validity is assessed via R²X (proportion of X variance explained), R²Y (proportion of class variance explained, goodness-of-fit), and Q² (cross-validated R²Y, predictive ability). Q² > 0.5 generally indicates a valid model; Q² close to R²Y indicates no overfitting. A permutation test (100 permutations, random class-label reassignment) confirms the model is not spurious (p < 0.05). PLS-DA can overfit with small sample sizes; cross-validation and permutation testing are mandatory, not optional.

9.3 Paired PCA Trajectory

Paired PCA trajectory plots display the movement of individual subjects through PCA score space across two or more paired conditions (e.g., pre/post treatment). PCA is computed on the full dataset; each subject's scores at each condition are connected by directed arrows indicating the direction of change, with arrow magnitude reflecting the Euclidean distance in PCA space. Parallel arrows indicate a consistent treatment effect; diverging arrows suggest heterogeneous responses; the group centroid summarizes the average trajectory. This method requires a subject identifier in the sample metadata and is meaningful only when pairing is correctly specified.

10.1 Test selection by data structure

Differential abundance analysis identifies features whose abundance differs significantly between groups, and the appropriate test depends on the data structure. The platform implements and recommends the following: Limma empirical Bayes moderated t-test (Smyth 2004) for continuous intensity data (microarray, log-transformed proteomics, metabolomics, lipidomics): it borrows variance information across all features via an empirical Bayes hierarchical model, shrinking per-feature variances toward a global prior and dramatically increasing power at small n (< 10 per group). DESeq2 (Love, Huber & Anders 2014) for RNA-seq count data: it models counts with a negative binomial distribution accounting for mean-dependent overdispersion, estimates size factors via the median-of-ratios, shrinks per-gene dispersion toward a fitted trend, and tests via the Wald test.

For small samples (n < 5 per group) or heavily skewed distributions, the Wilcoxon rank-sum test (Mann-Whitney U) is a robust non-parametric alternative with no normality assumption and Pitman efficiency ≈ 0.955 relative to the t-test when data are truly normal. For paired designs (pre/post, crossover), the paired t-test or subject-blocked Limma model accounts for inter-individual variability and is substantially more powerful than the unpaired equivalent. For multi-group designs, one-way ANOVA followed by Tukey HSD (family-wise error rate control) is appropriate for approximately normal data; Kruskal-Wallis is the non-parametric alternative. Fisher's exact test (median-binarized features) is available for very small n or binary outcomes.

10.2 Multiple testing correction

With hundreds to thousands of features tested simultaneously, the Benjamini-Hochberg FDR correction is the default and the standard for omics, controlling the expected proportion of false positives among significant findings. Bonferroni controls the family-wise error rate (probability of any false positive) and is considerably more conservative. Holm-Bonferroni is intermediate. Disabling correction is permitted only for hypothesis-generating preliminary analyses and is flagged in the reproducibility log. A combined threshold (e.g., |log₂FC| ≥ 1 AND adjusted p < 0.05) is recommended to filter for features that are both statistically significant and biologically meaningful: fold changes without significance produce many false positives; p-values without fold-change thresholds include many trivially small effects.

11.1 Over-Representation Analysis (ORA)

ORA tests whether a set of differentially abundant features contains more pathway members than expected by chance, using Fisher's exact test (hypergeometric test). For each pathway, a 2×2 contingency table is constructed (significant ∩ pathway, significant ∉ pathway, background ∩ pathway, background ∉ pathway), and the probability of observing at least the observed overlap under the null is computed. The enrichment ratio = (significant features in pathway / total significant) ÷ (pathway size / background size); values > 1 indicate over-representation. Benjamini-Hochberg FDR correction is applied across all tested pathways, with pathways containing fewer than 3 mapped features excluded to avoid spurious enrichment from tiny annotations.

The background set must be the full set of detected/tested features, not the entire theoretical proteome or metabolome, to reflect the actual detection space. ORA ignores fold-change magnitude and treats all significant features equally; it is sensitive to the significance threshold used to define the foreground set. Gene Set Enrichment Analysis (GSEA), which considers the full ranked list, is provided as a complementary approach.

12.1 Correlation analysis

Correlation analysis quantifies the strength and direction of linear (Pearson) or rank-based (Spearman) associations between omics features and/or phenotypic variables. Pearson measures linear association (−1 to +1), assumes bivariate normality, and is sensitive to outliers. Spearman is a non-parametric rank-based correlation robust to outliers and non-normal distributions, equivalent to Pearson applied to the ranks. When computing correlations for all features simultaneously, Benjamini-Hochberg FDR correction is applied to the matrix of p-values, with a combined threshold of |r| > 0.3 and adjusted p < 0.05 commonly used.

Correlation does not imply causation. Confounding variables create spurious associations, and very large sample sizes may yield statistically significant but practically trivial correlations. The platform reports both r and adjusted p, and recommends interpreting correlations alongside effect size and biological plausibility. For compositional data, SparCC or log-ratio-based correlations are preferred over Pearson to avoid spurious negative correlations induced by the constant-sum constraint.

12.2 Co-abundance network analysis

Co-abundance networks represent omics features as nodes and statistically significant pairwise correlations as edges, enabling identification of functional modules and hub features. Edges are drawn between feature pairs with |r| exceeding a user-defined threshold and adjusted p < 0.05, with edge thickness proportional to |r|. The Louvain algorithm (Blondel et al. 2008) iteratively optimizes network modularity Q, assigning nodes to communities that maximize intra-community edge density. Hub nodes, identified by degree centrality, are often biologically central: rate-limiting enzymes, key metabolic intermediates, or keystone taxa.

Network topology is highly sensitive to the correlation threshold and sample size; spurious edges appear with small samples. Correlation networks do not imply direct biochemical or ecological interactions. The platform recommends pairing network analysis with pathway enrichment applied to each module to interpret biological function and validating hub features experimentally.

13.1 Counterfactual mediation analysis

Counterfactual mediation analysis (Imai-Keele-Yamamoto framework) decomposes the total effect of an exposure on an outcome into the average causal mediation effect (ACME) transmitted through a mediator and the average direct effect (ADE). ACME = E[Y(t, M(t)) − Y(t, M(t′))]: the change in outcome when the exposure changes and the mediator is allowed to change naturally. ADE = E[Y(t, M(t′)) − Y(t′, M(t′))]: the change when the exposure changes but the mediator is fixed. Both are estimated via OLS regression with percentile bootstrap confidence intervals (default 1000 iterations).

The key identifying assumption is sequential ignorability: (i) no unmeasured confounding of the exposure-outcome relationship, and (ii) no unmeasured confounding of the mediator-outcome given the exposure. Sensitivity analysis via the ρ parameter (residual correlation between mediator and outcome model errors) quantifies robustness to assumption (ii): a finding that persists across a wide range of ρ is robust; one that nullifies at small ρ is fragile. Results are sensitive to model mis-specification; causal interpretation requires strong prior biological knowledge.

13.2 Mendelian randomization (two-sample MR)

Mendelian randomization uses genetic variants (SNPs) as instrumental variables to estimate the causal effect of a modifiable exposure on an outcome, analogous to a natural randomized experiment. Valid instruments must satisfy: (1) Relevance: the SNP is robustly associated with the exposure (F-statistic > 10); (2) Independence: the SNP is independent of confounders; (3) Exclusion restriction: the SNP affects the outcome only through the exposure. The inverse-variance weighted (IVW) estimator computes the causal effect as the weighted regression of SNP-outcome associations on SNP-exposure associations (slope = causal estimate), assuming all instruments are valid.

Sensitivity analyses address pleiotropy: MR-Egger fits a regression with an intercept to detect and correct directional pleiotropy; the weighted median estimator is consistent if ≥50% of instrument weight comes from valid instruments; the weighted mode is robust to a majority of invalid instruments; MR-PRESSO detects and removes pleiotropic outliers. MR estimates a population-average lifetime causal effect and may not reflect short-term interventions; violations of the IV assumptions bias estimates. The platform requires no sample overlap between exposure and outcome GWAS (two-sample design) and reliable effect-allele harmonization.

13.3 Directed Acyclic Graph (DAG) builder

DAGs encode prior causal knowledge as a directed graph and enable principled identification of the minimal adjustment set for unbiased causal effect estimation. A set Z satisfies the back-door criterion relative to (X, Y) if: (1) no variable in Z is a descendant of X, and (2) Z blocks every back-door path between X and Y. Adjusting for Z yields an unbiased estimate of the causal effect of X on Y. A collider: a variable with two or more causes on the same path: must not be conditioned on, as doing so opens a spurious path between its causes (collider bias). The platform's DAG builder applies the back-door criterion automatically and feeds the identified adjustment set into the mediation and regression modules.

13.4 Multi-layer sequential mediation

Multi-layer mediation extends counterfactual mediation to sequential causal chains (X → M1 → M2 → Y), decomposing the total effect into: (1) direct effect X→Y, (2) indirect through M1 only, (3) indirect through M2 only, and (4) fully sequential indirect through both mediators. Each pathway is estimated using a sequence of OLS regression models with bootstrap confidence intervals (1000 resamples). Sequential ignorability must hold for all mediator-outcome paths, the ordering of mediators must be justified by prior biological knowledge, and models assume linear relationships. This is used for multi-omics integration where a causal chain is hypothesized (e.g., epigenetics → transcriptomics → metabolomics → phenotype).

14.1 Alpha diversity

Alpha diversity quantifies within-sample ecological diversity. The Shannon index (H′ = −Σ pᵢ·ln(pᵢ)) captures richness and evenness, sensitive to rare taxa. The Simpson index (1−D, where D = Σ pᵢ²) emphasizes dominant taxa and is less sensitive to rare taxa. Chao1 is a non-parametric richness estimator correcting for single- and double-occurrence taxa (S_chao1 = S_obs + f₁²/(2·f₂)). Observed features is the raw count of distinct taxa; Faith's phylogenetic diversity sums branch lengths of the phylogenetic tree spanned by present taxa, requiring a rooted tree. Counts should be rarefied to equal depth or depth-corrected estimators used for fair cross-sample comparison. Multiple indices are reported because they capture different ecological facets and can disagree.

14.2 Beta diversity and ordination

Beta diversity measures between-sample dissimilarity. Bray-Curtis (BC = Σ|xᵢ−yᵢ| / Σ(xᵢ+yᵢ)) quantifies compositional dissimilarity, sensitive to abundant taxa. Jaccard (1 − |A∩B|/|A∪B|) is a presence/absence index emphasizing turnover. UniFrac (unweighted and weighted) uses phylogenetic branch lengths, requiring a rooted tree. The Aitchison distance (Euclidean distance of CLR-transformed profiles) is the proper compositional distance: subcompositionally coherent, unlike Bray-Curtis. Principal Coordinates Analysis (PCoA) projects the distance matrix into low-dimensional space; PERMANOVA (adonis2) tests whether group centroids differ, with R² = variance explained and a permutation p-value. PERMDISP (betadisper) must be checked to rule out dispersion effects masquerading as location effects.

14.3 LEfSe (Linear Discriminant Analysis Effect Size)

LEfSe identifies taxa characterizing class differences via a two-stage procedure: Stage 1 applies a Kruskal-Wallis test per taxon (p < α); Stage 2 scores only significant taxa with a class-conditional LDA, yielding an effect-size score (log₁₀ LDA). |LDA| > 2 is a conventional threshold for biologically meaningful discriminants. LEfSe tests relative abundances directly without compositional correction and can be confounded by library-size differences; it should be paired with a compositional method (ANCOM-BC2, ALDEx2) for confirmation.

14.4 ANCOM-BC2 (compositional with bias correction)

ANCOM-BC2 tests differential abundance while accounting for compositional structure and correcting sampling-fraction (library-size) bias via a log-linear model on absolute abundances. Each sample's unknown sampling fraction is estimated as a fixed offset; log-transformed absolute abundances are modeled with a per-sample bias term. The W-statistic counts, for each taxon, how many pairwise log-ratios against other taxa are significant: higher W indicates more robust signal. BH-FDR correction is applied across taxa; the W threshold (default 0.7 × number of taxa) controls family-wise error empirically. ANCOM-BC2 handles covariates, paired/repeated designs, and multi-group contrasts, and is the recommended primary method for differential abundance of count data.

14.5 ALDEx2 (ANOVA-like differential expression)

ALDEx2 models technical and sampling uncertainty by drawing 128 instances of a Dirichlet-Multinomial distribution from each sample's counts (with a small pseudocount), CLR-transforming each draw to produce a posterior distribution of log-ratios capturing count uncertainty. The statistical test (Welch's t or Wilcoxon) is performed across Monte-Carlo instances, with p-value and effect size summarized (median) over the posterior. ALDEx2 emphasizes effect size (Cohen's d) over p-values: effect > 0.5 combined with low BH q-value is conventionally meaningful. It is excellent for small cohorts and low-depth data where count uncertainty is large, though computationally heavier due to Monte-Carlo sampling.

14.6 Compositional ordination (Aitchison distance & robust PCA)

Compositional ordination uses log-ratio geometry: the Aitchison distance (Euclidean distance of CLR-transformed data) and Robust PCA (RPCA): to analyze microbiome data without the spurious correlations that Euclidean/Bray-Curtis methods introduce on relative abundances. The CLR transform (clr(x) = log(x) − mean(log(x))) maps compositions to real-valued vectors; RPCA decomposes the CLR matrix into low-rank structure plus sparse outliers via iterative principal component pursuit, more robust to outlier samples and sparse taxa than classical PCA. The CLR basis is singular (sums to zero), so PCoA can produce negative eigenvalues; the fraction of variance in negative eigenvalues is reported as a diagnostic (< 5% indicates a reliable ordination).

14.7 Covariate-adjusted PERMANOVA (adonis2) & PERMDISP

adonis2 extends PERMANOVA to a multivariate ANOVA design with multiple covariates, partitioning distance variation among terms by permuting residuals. Terms can be assessed sequentially (by = 'terms') or marginally (by = 'margin'); R² per term = fraction of distance variance explained. For paired or stratified designs, permutations are restricted within blocks to respect the design. PERMDISP (betadisper) computes the average distance of each group's samples to their centroid and tests for homogeneity of multivariate dispersions; a non-significant PERMDISP supports interpreting a significant PERMANOVA as a true centroid (location) difference rather than a dispersion effect.

14.8 Multivariable-adjusted differential abundance (MaAsLin2 / DESeq2 / corncob)

Three complementary regression frameworks identify taxa associated with a primary variable while adjusting for covariates. MaAsLin2 applies per-taxon linear regression on CLR-transformed abundance with arcsine-root or log transformation options, supporting fixed and random effects with BH-FDR correction: best for relative-abundance or transformed continuous profiles. DESeq2 models raw counts with a negative binomial GLM, estimating per-taxon dispersion shrunk toward a fitted trend and size factors via median-of-ratios, testing via the Wald test: best for raw count matrices. corncob models the proportion of each taxon as beta-binomial, jointly testing differential abundance (mean) and differential variability (dispersion): suited to mean-dependent overdispersion. Triangulating across methods is recommended for robust findings; rare taxa are unreliable in all three.

14.9 Machine learning suite (RF / SVM / k-NN / GNB / L2-Logistic)

An in-browser supervised classification suite benchmarks five algorithms: Random Forest, linear SVM, k-Nearest Neighbours, Gaussian Naive Bayes, and L2-regularised logistic regression: with nested cross-validation. An outer loop estimates generalization performance while an inner loop tunes hyperparameters (k, C, n trees/depth), avoiding the optimistic bias of single-loop CV when hyperparameters are selected on the same data. Per-feature importance is tracked across outer folds; features consistently important are robust biomarkers, unstable features are flagged. ROC curves and AUC summarize discriminative power. Small cohorts inflate performance estimates; class imbalance biases accuracy: macro-F1 and per-class ROC are reported. Feature importance is correlative, not causal.

14.10 DMM enterotyping (Dirichlet-Multinomial mixture)

DMM (Holmes et al. 2012) models the microbiome as a finite mixture of Dirichlet-Multinomial components, identifying discrete community states (enterotypes) without prior labels and selecting the number of types by BIC. Each enterotype is a DM component with a concentration vector α over taxa, capturing overdispersion characteristic of microbiome count data. EM estimation assigns samples softly to components (responsibilities) and updates α via Minka's fixed-point iterations. Fits K = 1..K_max and selects the K with the lowest BIC = −2·logL + p·log(N). DMM is sensitive to sequencing depth and taxonomic level; BIC can prefer K = 1 in small or homogeneous cohorts; enterotype labels are not biologically universal across studies.

14.11 FEAST microbial source tracking

FEAST (Shenhav et al. 2019) estimates the fractional contribution of each source community to a sink sample via an EM mixture model, with an explicit 'unknown' reservoir for unexplained sources. Each sink's composition is modeled as a mixture of source compositions plus a uniform unknown component; EM iteratively estimates mixing proportions. The unknown pool prevents over-attribution to under-sampled sources. The output is a per-sink vector of source proportions, visualized as a stacked bar chart. FEAST is sensitive to source representativeness and assumes source compositions are fixed.

14.12 Sloan neutral community model

The Sloan neutral model (Sloan et al. 2006; Burns et al. 2016) tests whether community assembly is governed by neutral (stochastic) processes: ecological drift plus immigration: by predicting each taxon's occurrence frequency from its mean relative abundance. For a taxon with mean relative abundance p in a local community of N reads, occurrence is predicted as P(Beta(N·m·p, N·m·(1−p)) > 1/N), where m is the immigration parameter fit by non-linear least squares. R² between observed and predicted occurrence quantifies the neutral fit; Wilson 95% confidence intervals define a neutral band; taxa above are overrepresented (selected for), below are underrepresented (selected against). A single well-mixed metacommunity is assumed; structured habitats violate this.

14.13 WGCNA (weighted co-occurrence network analysis)

WGCNA (Langfelder & Horvath 2008) constructs a weighted co-occurrence network from taxa, identifies modules of tightly co-occurring taxa, and correlates modules with external traits. A power β transforms the absolute correlation matrix into an adjacency emphasizing strong correlations (chosen to achieve approximate scale-free topology, R² > 0.8). Topological overlap (TOM) is computed and hierarchical clustering groups taxa into modules, merged if eigentaxa are highly correlated. Each module's eigentaxon is correlated with sample-level traits; modules with significant eigentaxon-trait correlations are trait-associated, and hub taxa within them are candidate biomarkers. Requires ≥15 samples (ideally ≥20) for stable correlation estimates; co-occurrence can arise from shared environmental drivers rather than biological interaction.

14.14 MAG analysis (metagenome-assembled genomes)

MAG analysis works with binned metagenomic assemblies to summarize taxonomy, phylogeny (ANI), functional gene content, and novelty. Each MAG is assessed by completion and contamination (CheckM); high-quality bins (completion ≥90%, contamination <5%) are retained. Average nucleotide identity (ANI) between bins builds a phylogenetic tree; ANI > 95% conventionally denotes the same species. COG/KEGG annotations per bin are aggregated and enriched functions identified via Fisher exact tests with BH-FDR. Bin quality drives all downstream results: contaminated or chimeric bins mislead; ANI is a coarse species proxy; novel bins lack reference-based validation.

14.15 Microbiome-metabolite integration

Integrates taxonomic profiles with metabolomics to identify metabolites associated with specific microbes. Pairwise correlations (Spearman/Pearson) are computed between each taxon and each metabolite across shared samples; significant pairs (|r| > threshold, BH-FDR < 0.05) form a bipartite association network. Correlations can be stratified by a metadata variable to reveal group-specific links. Strong taxon-metabolite associations suggest the microbe produces, consumes, or co-regulates the metabolite, but correlation does not establish production; confounding by diet, medication, or host metabolism is a concern. Both tables must be normalised to comparable scales and samples must be matched.

15.1 Cross-omics correlation and module detection

Multi-omics integration correlates features from different omics layers (e.g., lipidomics + transcriptomics) to identify cross-layer associations, co-regulated modules, and multi-omics biomarkers. Pairwise Pearson or Spearman correlations are computed between all feature pairs across layers; significant edges (|r| > threshold, adjusted p < 0.05) build a bipartite network. Community detection (Louvain) on the cross-omics network identifies co-regulated modules spanning multiple layers. Logistic regression with L1/L2 regularization (elastic net) selects a sparse multi-omics feature panel predictive of group membership. Cross-omics correlations require carefully matched samples; high dimensionality increases the multiple testing burden.

16.1 Preprocessing, dimensionality reduction, and clustering

Single-cell workflows begin with quality filtering (removing low-quality cells and doublets based on per-cell gene counts, UMI counts, and mitochondrial fraction), followed by normalization (e.g., library-size normalization and log-transformation, or SCTransform variance-stabilizing normalization). Highly variable genes are selected to reduce dimensionality, and PCA is applied to the normalized, scaled expression matrix. Non-linear dimensionality reduction (UMAP, t-SNE) projects cells into 2D for visualization. Graph-based clustering (Louvain or Leiden on a k-nearest-neighbor graph built in PCA space) identifies cell communities, which are then annotated by marker gene expression or reference-based annotation tools.

Trajectory analysis orders cells along a pseudotime axis reflecting developmental or activation progression, using diffusion maps, slingshot, or RNA velocity. Cell-cell communication is inferred from ligand-receptor expression (e.g., CellChat-style analysis). All steps are documented in a reproducibility log so the exact filtering thresholds, HVG count, PCA dimensions, clustering resolution, and annotation references are recoverable.

17.1 Olink NPX data and differential protein analysis

The proteomics workflow supports Olink NPX (Normalized Protein eXpression) data, which are log₂-transformed relative protein quantities measured via proximity extension assays. QC includes sample distribution inspection, missingness assessment, LOD filtering, CV quality assessment, and plate-effect detection. Differential protein analysis applies Limma empirical Bayes on NPX values, with support for covariates, paired/longitudinal designs, and continuous outcomes. Enrichment analysis maps UniProt IDs to gene symbols and performs pathway ORA/GSEA, PPI network construction, and tissue-enrichment analysis. Advanced modules include PLS-DA, elastic-net biomarker selection, ROC analysis, and survival analysis.

18.1 Independent reference implementations

Every statistical engine implemented in the platform is validated against an independent reference implementation written from scratch in JavaScript, following the published mathematical formulation of each algorithm. The reference implementations do not share code with the platform's engines: they are an independent validation oracle. Where multiple algorithms exist for the same computation, different ones are used in the reference and the platform (e.g., Jacobi eigendecomposition for reference PCA vs. power-iteration deflation in the platform), strengthening the independence of the comparison and ensuring that agreement is not an artifact of shared numerical paths.

The benchmarking suite covers all six omics workflows: transcriptomics (Welch's t-test, Wilcoxon rank-sum, Benjamini-Hochberg FDR, PCA, limma empirical Bayes), metabolomics (Welch's t-test, BH correction, PCA, log₂ fold change), lipidomics (Welch's t-test, BH correction, PCA, Cohen's d), proteomics (limma on NPX data, BH correction, PCA), metagenomics (Shannon entropy, Simpson index, Chao1, Bray-Curtis dissimilarity), and single-cell (PCA on log-normalized counts, k-means clustering). Each method is tested on a deterministic, gold-standard dataset modeled on published reference designs (SEQC/MAQC, MetaboLights, LIPID MAPS, Olink/ProteomeXchange, CAMI/QIIME2, 10x Genomics pbmc3k).

18.2 Equivalence criteria and results

Equivalence is assessed against three criteria matched to the output type. For continuous outputs (p-values, fold changes, ordination scores), a Pearson correlation coefficient r ≥ 0.999 between the platform's output and the reference implementation's output is required for a PASS. For deterministic computations (PCA scores, distance matrices), the maximum relative error must not exceed 10⁻⁶. For discrete outputs (cluster assignments, pathway membership), 100% exact match is required (with label permutation permitted for clustering, since cluster labels are arbitrary). These thresholds are conservative: r ≥ 0.999 means the platform and reference explain 99.8% of each other's variance, far exceeding the level at which downstream biological interpretation would be affected.

The benchmark runs entirely client-side in the browser. It uploads nothing and needs no server call: the datasets and the reference implementations are bundled with the platform, so any reviewer or user can re-run the benchmark at any time. Results are displayed on the platform's Validation page (omics.omvitalis.com/validation) and are downloadable as CSV for inclusion in supplementary materials. The platform's separate server-side analysis paths are named in its data-egress table, and this benchmark is not one of them. The full equivalence tables: per-method Pearson r, maximum absolute and relative error, and pass/fail status: are available for inspection and citation. This level of validation transparency is designed to meet the code availability and reproducibility requirements of journals such as Nature Methods, while preserving the platform's proprietary product layer.

19.1 Freeform composition and reproducibility metadata

The Figure Builder allows composition of multi-panel figures from individual analysis outputs in a freeform canvas, with panel positioning, resizing, annotations, titles, and consolidated legends. Layouts are saved as exact snapshots of panel geometry and edits, ensuring a saved layout restores precisely. Journal-specific sizing presets (Nature, Cell, etc.) enforce submission-compliant dimensions. Every exported figure (SVG, PNG, PDF, TIFF) embeds reproducibility metadata: platform version, workflow, color palette, axis-link configuration: as structured data within the file, so a published figure is self-documenting.

The export pipeline supports vector formats (SVG, PDF) preserving scalability and raster formats (PNG, TIFF) at 300, 600, and 1200 DPI via canvas-based compositing that avoids the rendering failures associated with large nested SVGs. Individual SVG panels are pre-rasterized to PNG before compositing to bypass browser-native SVG rasterization failures for nested elements. The format and DPI are recorded in the embedded metadata so a reviewer can confirm the published figure is a faithful representation of the analysis output.